publication . Article . 2016

Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer

María del Mar Valenzuela-Membrives; Francisco Perea-García; Abel Sanchez-Palencia; Francisco Ruiz-Cabello; Mercedes Gómez-Morales; María Teresa Miranda-León; Inmaculada Galindo-Angel; María Esther Fárez-Vidal;
Open Access English
  • Published: 01 Sep 2016 Journal: Oncotarget, volume 7, issue 44, pages 71,608-71,619 (eissn: 1949-2553, Copyright policy)
  • Publisher: Impact Journals LLC
Abstract
// Maria del Mar Valenzuela-Membrives 1 , Francisco Perea-Garcia 3 , Abel Sanchez- Palencia 2 , Francisco Ruiz-Cabello 3 , Mercedes Gomez-Morales 4 , Maria Teresa Miranda-Leon 5 , Inmaculada Galindo-Angel 4 , Maria Esther Farez-Vidal 6 1 Department of Pneumology, San Cecilio University Hospital, Granada, Spain 2 Department of Thoracic Surgery, Virgen de las Nieves University Hospital, Granada, Spain 3 Institute for Biomedical Research, Virgen de las Nieves University Hospital, Granada, Spain 4 Department of Pathology, School of Medicine, University of Granada, Granada, Spain 5 Department of Statistics and Operative Research, School of Medicine, University of Gra...
Subjects
free text keywords: Research Paper, immunological response, lung cancer, immunohistochemistry, flow cytometry, lymphocyte subsets, Oncology, Lymphocyte, medicine.anatomical_structure, medicine, Immunosurveillance, CD8, Cancer, medicine.disease, Adenocarcinoma, business.industry, business, Immunology, Immune system, Cytotoxic T cell, Pathology, medicine.medical_specialty
Related Organizations
56 references, page 1 of 4

Molina, JR, Yang, P, Cassivi, SD, Schild, SE, Adjei, AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008; 83: 584-94 [OpenAIRE] [PubMed]

Fridman, WH, Pagès, F, Sautès-Fridman, C, Galon, J. Nature Rev Cancer. 2012; 12: 298-306 [PubMed]

Jemal, A, Siegel, R, Ward, E, Murray, T, Xu, J, Smigal, C, Thun, MJ. CA Cancer J. Clin. 2006; 56: 106-30

Zou, W. Regulatory T cells, tumour immunity and immunotherapy. Nature Reviews Immunology. 2006; 6: 295-307

Atreya, I, Neurath, M. F. Immune cells in colorectal cancer: Prognostic relevance and therapeutic strategies. Expert Rev Anticancer. 2008; 8: 561-572

Bindea, G, Mlecnik, B, Fridman, WH, Pages, F, Galon, J. Natural immunity to cancer in humans. Curr Opin Immunol. 2010; 22: 215-222 [OpenAIRE] [PubMed]

Galon, J, Costes, A, Sanchez-Cabo, F, Kirilovsky, A, Mlecnik, B, Lagorce-Pagès, C, Tosolini, M, Camus, M, Berger, A, Wind, P, Zinzindohoué, F, Bruneval, P, Cugnenc, PH. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313: 1960-1964 [OpenAIRE] [PubMed]

Mlecnik, B, Tosolini, M, Kirilovsky, A, Berger, A, Bindea, G, Meatchi, T, Bruneval, P, Trajanoski, Z, Fridman, WH, Pagès, F, Galon, J. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011; 29: 610-8 [OpenAIRE] [PubMed]

Brambilla, E, Le Teuff, G, Marguet, S, Lantuejoul, S, Dunant, A, Graziano, S, Pirker, R, Douillard, JY, Le Chevalier, T, Filipts, M, Rosell, R, Kratzke, R, Popper, H. Prognostic effect of tumor lymphocytic infiltration in resectable non-small cell lung cancer. J of Clin Oncol. 2016; 34: 1223-30 [OpenAIRE] [PubMed]

Mantovani, A, Sica, A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010; 22: 231-7 [PubMed]

Pagès, F, Kirilovsky, A, Mlecnik, B, Asslaber, M, Tosolini, M, Bindea, G, Lagorce, C, Wind, P, Marliot, F, Bruneval, P, Zatloukal, K, Trajanoski, Z, Berger, A. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol. 2009; 27: 5944-51 [OpenAIRE] [PubMed]

Ronald, J, deLeeuw, null, Kost, Sara E, Kakal, Juzer A, Nelson, Brad H. The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clinical Cancer Research. 2012; 18: 3022-29 [PubMed]

Tao, H, Mimura, Y, Aoe, K, Kobayashi, S, Yamamoto, H, Matsuda, E, Okabe, K, Matsumoto, T, Sugi, K, Ueoka, H. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Lung Cancer. 2012; 75: 95-101 [PubMed]

Duraiswamy, J, Kaluza, KM, Freeman, GJ, Coukos, G. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Cancer Res. 2013; 73: 3591-603 [OpenAIRE] [PubMed]

Ljunggren, HG, Malmberg, KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nature Reviews Immunology. 2007; 7: 329-39

56 references, page 1 of 4
Abstract
// Maria del Mar Valenzuela-Membrives 1 , Francisco Perea-Garcia 3 , Abel Sanchez- Palencia 2 , Francisco Ruiz-Cabello 3 , Mercedes Gomez-Morales 4 , Maria Teresa Miranda-Leon 5 , Inmaculada Galindo-Angel 4 , Maria Esther Farez-Vidal 6 1 Department of Pneumology, San Cecilio University Hospital, Granada, Spain 2 Department of Thoracic Surgery, Virgen de las Nieves University Hospital, Granada, Spain 3 Institute for Biomedical Research, Virgen de las Nieves University Hospital, Granada, Spain 4 Department of Pathology, School of Medicine, University of Granada, Granada, Spain 5 Department of Statistics and Operative Research, School of Medicine, University of Gra...
Subjects
free text keywords: Research Paper, immunological response, lung cancer, immunohistochemistry, flow cytometry, lymphocyte subsets, Oncology, Lymphocyte, medicine.anatomical_structure, medicine, Immunosurveillance, CD8, Cancer, medicine.disease, Adenocarcinoma, business.industry, business, Immunology, Immune system, Cytotoxic T cell, Pathology, medicine.medical_specialty
Related Organizations
56 references, page 1 of 4

Molina, JR, Yang, P, Cassivi, SD, Schild, SE, Adjei, AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008; 83: 584-94 [OpenAIRE] [PubMed]

Fridman, WH, Pagès, F, Sautès-Fridman, C, Galon, J. Nature Rev Cancer. 2012; 12: 298-306 [PubMed]

Jemal, A, Siegel, R, Ward, E, Murray, T, Xu, J, Smigal, C, Thun, MJ. CA Cancer J. Clin. 2006; 56: 106-30

Zou, W. Regulatory T cells, tumour immunity and immunotherapy. Nature Reviews Immunology. 2006; 6: 295-307

Atreya, I, Neurath, M. F. Immune cells in colorectal cancer: Prognostic relevance and therapeutic strategies. Expert Rev Anticancer. 2008; 8: 561-572

Bindea, G, Mlecnik, B, Fridman, WH, Pages, F, Galon, J. Natural immunity to cancer in humans. Curr Opin Immunol. 2010; 22: 215-222 [OpenAIRE] [PubMed]

Galon, J, Costes, A, Sanchez-Cabo, F, Kirilovsky, A, Mlecnik, B, Lagorce-Pagès, C, Tosolini, M, Camus, M, Berger, A, Wind, P, Zinzindohoué, F, Bruneval, P, Cugnenc, PH. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313: 1960-1964 [OpenAIRE] [PubMed]

Mlecnik, B, Tosolini, M, Kirilovsky, A, Berger, A, Bindea, G, Meatchi, T, Bruneval, P, Trajanoski, Z, Fridman, WH, Pagès, F, Galon, J. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011; 29: 610-8 [OpenAIRE] [PubMed]

Brambilla, E, Le Teuff, G, Marguet, S, Lantuejoul, S, Dunant, A, Graziano, S, Pirker, R, Douillard, JY, Le Chevalier, T, Filipts, M, Rosell, R, Kratzke, R, Popper, H. Prognostic effect of tumor lymphocytic infiltration in resectable non-small cell lung cancer. J of Clin Oncol. 2016; 34: 1223-30 [OpenAIRE] [PubMed]

Mantovani, A, Sica, A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010; 22: 231-7 [PubMed]

Pagès, F, Kirilovsky, A, Mlecnik, B, Asslaber, M, Tosolini, M, Bindea, G, Lagorce, C, Wind, P, Marliot, F, Bruneval, P, Zatloukal, K, Trajanoski, Z, Berger, A. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol. 2009; 27: 5944-51 [OpenAIRE] [PubMed]

Ronald, J, deLeeuw, null, Kost, Sara E, Kakal, Juzer A, Nelson, Brad H. The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clinical Cancer Research. 2012; 18: 3022-29 [PubMed]

Tao, H, Mimura, Y, Aoe, K, Kobayashi, S, Yamamoto, H, Matsuda, E, Okabe, K, Matsumoto, T, Sugi, K, Ueoka, H. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Lung Cancer. 2012; 75: 95-101 [PubMed]

Duraiswamy, J, Kaluza, KM, Freeman, GJ, Coukos, G. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Cancer Res. 2013; 73: 3591-603 [OpenAIRE] [PubMed]

Ljunggren, HG, Malmberg, KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nature Reviews Immunology. 2007; 7: 329-39

56 references, page 1 of 4
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2016

Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer

María del Mar Valenzuela-Membrives; Francisco Perea-García; Abel Sanchez-Palencia; Francisco Ruiz-Cabello; Mercedes Gómez-Morales; María Teresa Miranda-León; Inmaculada Galindo-Angel; María Esther Fárez-Vidal;